OPKO Health (OPK) EV/EBITDA: History & Chart

OPKO Health, Inc.(OPK)

Medical - Diagnostics & Research · Miami, FL

$1.46-0.11 (-7.01%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About OPKO Health, Inc.

OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease detection, diagnosis, evaluation, monitoring, and treatment, covering areas such as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare. BioReference serves a diverse client base, including medical practices, clinics, hospitals, employers, and government entities. Additionally, this segment provides a cutting-edge diagnostic instrument system designed for immediate, point-of-care blood test results, alongside its specialized 4Kscore testing for prostate cancer. Within the Pharmaceutical segment, OPKO offers a range of therapeutic products and a robust development pipeline. Key offerings include Rayaldee, indicated for the management of secondary hyperparathyroidism in adults suffering from stage 3 or 4 chronic kidney disease and vitamin D insufficiency. The pipeline features OPK88004, an investigational orally administered selective androgen receptor modulator; OPK88003, a peptide administered once weekly currently in Phase IIb trials for the treatment of type 2 diabetes and obesity; and hGH-CTP, a once-weekly human growth hormone injection that has successfully completed Phase III clinical trials in collaboration with Pfizer, Inc. A core strategy for this segment involves the development and commercialization of proprietary, extended-release versions of existing therapeutic proteins. Furthermore, OPKO Health supplies specialty active pharmaceutical ingredients (APIs) and is involved in the development, manufacturing, marketing, and sale of pharmaceutical, nutraceutical, veterinary, and ophthalmic products. The company also commercializes food supplements and over-the-counter products, produces and sells items primarily within the generics market, and handles the import, marketing, distribution, and sales of pharmaceutical products across various therapeutic areas, including cardiovascular conditions, vaccines, antibiotics, gastro-intestinal ailments, and hormone-related treatments, among others. Its pharmaceutical operations are further bolstered by platforms situated in Ireland, Chile, Spain, and Mexico. Founded in 1991, OPKO Health, Inc. maintains its corporate headquarters in Miami, Florida.

Miami, FL

2,275 employees

www.opko.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Phillip Frost

View full financials

OPK EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

12.56x

EV/EBITDA RATIO AVG 3Y

15.52x

EV/EBITDA RATIO AVG 5Y

15.52x

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
OPKO Health, Inc. (OPK)	$1.09B	N/A	12.56x	15.52x	15.52x
First Tracks Biotherapeutics Inc (TRAX)vs ›	$1.09B	N/A	N/A	N/A	N/A
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.09B	N/A	N/A	N/A	N/A
IRadimed Corporation (IRMD)vs ›	$1.08B	34.85x	40.48x	32.62x	34.28x
STAAR Surgical Company (STAA)vs ›	$1.10B	22.47x	239.72x	94.93x	89.53x
Tandem Diabetes Care, Inc. (TNDM)vs ›	$1.10B	N/A	279.36x	538.48x	538.48x
Replimune Group, Inc. (REPL)vs ›	$1.11B	N/A	N/A	N/A	N/A
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.13B	N/A	N/A	N/A	N/A
Teladoc Health, Inc. (TDOC)vs ›	$1.05B	12.91x	29.00x	192.84x	192.84x
Harrow Health, Inc. (HROW)vs ›	$1.13B	N/A	44.15x	171.76x	154.47x

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

OPKO Health, Inc. (OPK)

$1.09B

N/A

12.56x

15.52x

First Tracks Biotherapeutics Inc (TRAX)vs ›

$1.09B

N/A

Bicara Therapeutics Inc. Common Stock (BCAX)vs ›

$1.09B

N/A

IRadimed Corporation (IRMD)vs ›

$1.08B

34.85x

40.48x

32.62x

34.28x

STAAR Surgical Company (STAA)vs ›

$1.10B

22.47x

239.72x

94.93x

89.53x

Tandem Diabetes Care, Inc. (TNDM)vs ›

$1.10B

N/A

279.36x

538.48x

Replimune Group, Inc. (REPL)vs ›

$1.11B

N/A

Avalyn Pharma Inc. Common Stock (AVLN)vs ›

$1.13B

N/A

Teladoc Health, Inc. (TDOC)vs ›

$1.05B

12.91x

29.00x

192.84x

Harrow Health, Inc. (HROW)vs ›

$1.13B

N/A

44.15x

171.76x

154.47x

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for OPKO Health, Inc. (OPK)?

The EV/EBITDA ratio for OPK stock is N/A.

What is the estimated TTM average EV/EBITDA ratio for OPKO Health, Inc. (OPK)?

The estimated TTM average EV/EBITDA ratio for OPK stock is 12.56x.

What is the estimated 3Y average EV/EBITDA ratio for OPKO Health, Inc. (OPK)?

The estimated 3Y average EV/EBITDA ratio for OPK stock is 15.52x.

What is the estimated 5Y average EV/EBITDA ratio for OPKO Health, Inc. (OPK)?

The estimated 5Y average EV/EBITDA ratio for OPK stock is 15.52x.

DATE	EV/EBITDA RATIO
2022-05-09	17.55x
2022-05-06	18.75x
2022-05-05	19.55x
2022-05-04	21.29x
2022-05-03	20.56x
2022-05-02	19.96x
2022-04-29	19.29x
2022-04-28	20.09x
2022-04-27	19.76x
2022-04-26	19.89x
2022-04-25	21.16x
2022-04-22	20.83x
2022-04-21	21.49x
2022-04-20	22.63x
2022-04-19	22.70x
2022-04-18	22.43x
2022-04-14	23.57x
2022-04-13	24.70x
2022-04-12	24.24x
2022-04-11	23.17x
2022-04-08	23.97x
2022-04-07	24.30x
2022-04-06	24.50x
2022-04-05	24.57x
2022-04-04	25.37x
2022-04-01	24.70x
2022-03-31	24.24x
2022-03-30	24.90x
2022-03-29	26.31x
2022-03-28	25.17x
2022-03-25	24.70x
2022-03-24	24.50x
2022-03-23	24.30x
2022-03-22	25.31x
2022-03-21	25.11x
2022-03-18	26.24x
2022-03-17	25.64x
2022-03-16	24.50x
2022-03-15	23.43x
2022-03-14	21.63x
2022-03-11	22.10x
2022-03-10	23.17x
2022-03-09	22.70x
2022-03-08	21.90x
2022-03-07	22.10x
2022-03-04	21.69x
2022-03-03	22.30x
2022-03-02	22.56x
2022-03-01	10.01x
2022-02-28	10.14x
2022-02-25	10.35x
2022-02-24	10.45x
2022-02-23	9.67x
2022-02-22	9.80x
2022-02-18	10.20x
2022-02-17	10.17x
2022-02-16	10.63x
2022-02-15	10.63x
2022-02-14	9.80x
2022-02-11	10.04x
2022-02-10	10.32x
2022-02-09	10.60x
2022-02-08	10.32x
2022-02-07	10.54x
2022-02-04	10.45x
2022-02-03	10.35x
2022-02-02	9.86x
2022-02-01	9.92x
2022-01-31	10.14x
2022-01-28	9.58x
2022-01-27	9.33x
2022-01-26	9.46x
2022-01-25	9.77x
2022-01-24	10.45x
2022-01-21	13.57x
2022-01-20	13.94x
2022-01-19	14.16x
2022-01-18	15.05x
2022-01-14	14.47x
2022-01-13	13.69x
2022-01-12	14.19x
2022-01-11	14.65x
2022-01-10	14.75x
2022-01-07	14.22x
2022-01-06	14.78x
2022-01-05	14.37x
2022-01-04	14.90x
2022-01-03	15.70x
2021-12-31	15.33x
2021-12-30	15.43x
2021-12-29	15.86x
2021-12-28	15.46x
2021-12-27	16.38x
2021-12-23	15.21x
2021-12-22	14.71x
2021-12-21	14.25x
2021-12-20	14.16x
2021-12-17	14.10x
2021-12-16	12.80x
2021-12-15	13.07x
2021-12-14	12.21x
2021-12-13	12.49x
2021-12-10	12.43x
2021-12-09	12.43x
2021-12-08	12.89x
2021-12-07	12.52x
2021-12-06	12.24x
2021-12-03	12.39x
2021-12-02	12.73x
2021-12-01	12.39x
2021-11-30	12.61x
2021-11-29	13.11x
2021-11-26	13.23x
2021-11-24	13.79x
2021-11-23	13.60x
2021-11-22	13.66x
2021-11-19	13.91x
2021-11-18	13.79x
2021-11-17	14.19x
2021-11-16	13.26x
2021-11-15	12.95x
2021-11-12	13.20x
2021-11-11	13.11x
2021-11-10	13.04x
2021-11-09	13.23x
2021-11-08	13.35x
2021-11-05	13.04x
2021-11-04	13.26x
2021-11-03	14.16x
2021-11-02	13.32x
2021-11-01	12.33x
2021-10-29	12.18x
2021-10-28	13.00x
2021-10-27	12.70x
2021-10-26	12.77x
2021-10-25	12.77x
2021-10-22	13.07x
2021-10-21	13.10x
2021-10-20	13.16x
2021-10-19	13.26x
2021-10-18	13.10x
2021-10-15	13.16x
2021-10-14	13.30x
2021-10-13	13.20x
2021-10-12	13.13x
2021-10-11	13.26x
2021-10-08	13.07x
2021-10-07	13.23x
2021-10-06	13.07x
2021-10-05	12.84x
2021-10-04	12.51x
2021-10-01	12.70x
2021-09-30	12.93x
2021-09-29	12.90x
2021-09-28	13.00x
2021-09-27	13.16x
2021-09-24	13.26x
2021-09-23	13.69x
2021-09-22	13.43x
2021-09-21	13.49x
2021-09-20	13.40x
2021-09-17	13.89x
2021-09-16	13.49x
2021-09-15	13.23x
2021-09-14	12.38x
2021-09-13	12.70x
2021-09-10	12.64x
2021-09-09	12.97x
2021-09-08	12.64x
2021-09-07	12.70x
2021-09-03	13.00x
2021-09-02	13.76x
2021-09-01	13.59x
2021-08-31	13.63x
2021-08-30	13.56x
2021-08-27	13.63x
2021-08-26	13.36x
2021-08-25	13.49x
2021-08-24	13.36x
2021-08-23	13.63x
2021-08-20	13.00x
2021-08-19	12.28x
2021-08-18	12.61x
2021-08-17	13.16x
2021-08-16	12.90x
2021-08-13	13.03x
2021-08-12	13.26x
2021-08-11	13.20x
2021-08-10	13.10x
2021-08-09	13.23x
2021-08-06	13.46x
2021-08-05	13.30x
2021-08-04	12.84x
2021-08-03	12.80x
2021-08-02	12.61x
2021-07-30	12.24x
2021-07-29	11.78x
2021-07-28	12.25x
2021-07-27	11.46x
2021-07-26	11.32x
2021-07-23	11.52x
2021-07-22	11.64x
2021-07-21	11.75x
2021-07-20	11.43x
2021-07-19	11.20x
2021-07-16	11.11x
2021-07-15	11.23x
2021-07-14	11.17x
2021-07-13	11.58x
2021-07-12	11.99x
2021-07-09	12.60x
2021-07-08	12.25x
2021-07-07	12.13x
2021-07-06	12.37x
2021-07-02	12.60x
2021-07-01	13.27x
2021-06-30	12.72x
2021-06-29	12.80x
2021-06-28	12.48x
2021-06-25	12.16x
2021-06-24	11.90x
2021-06-23	11.70x
2021-06-22	12.10x
2021-06-21	11.93x
2021-06-18	11.70x
2021-06-17	12.10x
2021-06-16	11.90x
2021-06-15	11.67x
2021-06-14	11.49x
2021-06-11	11.75x
2021-06-10	11.93x
2021-06-09	11.96x
2021-06-08	11.99x
2021-06-07	12.08x
2021-06-04	11.43x
2021-06-03	11.61x
2021-06-02	11.90x
2021-06-01	11.43x
2021-05-28	12.05x
2021-05-27	12.22x
2021-05-26	12.16x
2021-05-25	11.52x
2021-05-24	11.87x
2021-05-21	11.55x
2021-05-20	11.67x
2021-05-19	11.41x
2021-05-18	11.43x
2021-05-17	11.43x
2021-05-14	11.70x
2021-05-13	10.85x
2021-05-12	10.62x
2021-05-11	10.88x
2021-05-10	11.22x
2021-05-07	11.99x
2021-05-06	12.57x
2021-05-05	12.80x
2021-05-04	12.45x
2021-05-03	12.83x
2021-04-30	12.86x
2021-04-29	12.89x

DATE

EV/EBITDA RATIO

2022-05-09

17.55x

2022-05-06

18.75x

2022-05-05

19.55x

2022-05-04

21.29x

2022-05-03

20.56x

2022-05-02

19.96x

2022-04-29

19.29x

2022-04-28

20.09x

2022-04-27

19.76x

2022-04-26

19.89x

2022-04-25

21.16x

2022-04-22

20.83x

2022-04-21

21.49x

2022-04-20

22.63x

2022-04-19

22.70x

2022-04-18

22.43x

2022-04-14

23.57x

2022-04-13

24.70x

2022-04-12

24.24x

2022-04-11

23.17x

2022-04-08

23.97x

2022-04-07

24.30x

2022-04-06

24.50x

2022-04-05

24.57x

2022-04-04

25.37x

2022-04-01

24.70x

2022-03-31

24.24x

2022-03-30

24.90x

2022-03-29

26.31x

2022-03-28

25.17x

2022-03-25

24.70x

2022-03-24

24.50x

2022-03-23

24.30x

2022-03-22

25.31x

2022-03-21

25.11x

2022-03-18

26.24x

2022-03-17

25.64x

2022-03-16

24.50x

2022-03-15

23.43x

2022-03-14

21.63x

2022-03-11

22.10x

2022-03-10

23.17x

2022-03-09

22.70x

2022-03-08

21.90x

2022-03-07

22.10x

2022-03-04

21.69x

2022-03-03

22.30x

2022-03-02

22.56x

2022-03-01

10.01x

2022-02-28

10.14x

2022-02-25

10.35x

2022-02-24

10.45x

2022-02-23

9.67x

2022-02-22

9.80x

2022-02-18

10.20x

2022-02-17

10.17x

2022-02-16

10.63x

2022-02-15

10.63x

2022-02-14

9.80x

2022-02-11

10.04x

2022-02-10

10.32x

2022-02-09

10.60x

2022-02-08

10.32x

2022-02-07

10.54x

2022-02-04

10.45x

2022-02-03

10.35x

2022-02-02

9.86x

2022-02-01

9.92x

2022-01-31

10.14x

2022-01-28

9.58x

2022-01-27

9.33x

2022-01-26

9.46x

2022-01-25

9.77x

2022-01-24

10.45x

2022-01-21

13.57x

2022-01-20

13.94x

2022-01-19

14.16x

2022-01-18

15.05x

2022-01-14

14.47x

2022-01-13

13.69x

2022-01-12

14.19x

2022-01-11

14.65x

2022-01-10

14.75x

2022-01-07

14.22x

2022-01-06

14.78x

2022-01-05

14.37x

2022-01-04

14.90x

2022-01-03

15.70x

2021-12-31

15.33x

2021-12-30

15.43x

2021-12-29

15.86x

2021-12-28

15.46x

2021-12-27

16.38x

2021-12-23

15.21x

2021-12-22

14.71x

2021-12-21

14.25x

2021-12-20

14.16x

2021-12-17

14.10x

2021-12-16

12.80x

2021-12-15

13.07x

2021-12-14

12.21x

2021-12-13

12.49x

2021-12-10

12.43x

2021-12-09

12.43x

2021-12-08

12.89x

2021-12-07

12.52x

2021-12-06

12.24x

2021-12-03

12.39x

2021-12-02

12.73x

2021-12-01

12.39x

2021-11-30

12.61x

2021-11-29

13.11x

2021-11-26

13.23x

2021-11-24

13.79x

2021-11-23

13.60x

2021-11-22

13.66x

2021-11-19

13.91x

2021-11-18

13.79x

2021-11-17

14.19x

2021-11-16

13.26x

2021-11-15

12.95x

2021-11-12

13.20x

2021-11-11

13.11x

2021-11-10

13.04x

2021-11-09

13.23x

2021-11-08

13.35x

2021-11-05

13.04x

2021-11-04

13.26x

2021-11-03

14.16x

2021-11-02

13.32x

2021-11-01

12.33x

2021-10-29

12.18x

2021-10-28

13.00x

2021-10-27

12.70x

2021-10-26

12.77x

2021-10-25

12.77x

2021-10-22

13.07x

2021-10-21

13.10x

2021-10-20

13.16x

2021-10-19

13.26x

2021-10-18

13.10x

2021-10-15

13.16x

2021-10-14

13.30x

2021-10-13

13.20x

2021-10-12

13.13x

2021-10-11

13.26x

2021-10-08

13.07x

2021-10-07

13.23x

2021-10-06

13.07x

2021-10-05

12.84x

2021-10-04

12.51x

2021-10-01

12.70x

2021-09-30

12.93x

2021-09-29

12.90x

2021-09-28

13.00x

2021-09-27

13.16x

2021-09-24

13.26x

2021-09-23

13.69x

2021-09-22

13.43x

2021-09-21

13.49x

2021-09-20

13.40x

2021-09-17

13.89x

2021-09-16

13.49x

2021-09-15

13.23x

2021-09-14

12.38x

2021-09-13

12.70x

2021-09-10

12.64x

2021-09-09

12.97x

2021-09-08

12.64x

2021-09-07

12.70x

2021-09-03

13.00x

2021-09-02

13.76x

2021-09-01

13.59x

2021-08-31

13.63x

2021-08-30

13.56x

2021-08-27

13.63x

2021-08-26

13.36x

2021-08-25

13.49x

2021-08-24

13.36x

2021-08-23

13.63x

2021-08-20

13.00x

2021-08-19

12.28x

2021-08-18

12.61x

2021-08-17

13.16x

2021-08-16

12.90x

2021-08-13

13.03x

2021-08-12

13.26x

2021-08-11

13.20x

2021-08-10

13.10x

2021-08-09

13.23x

2021-08-06

13.46x

2021-08-05

13.30x

2021-08-04

12.84x

2021-08-03

12.80x

2021-08-02

12.61x

2021-07-30

12.24x

2021-07-29

11.78x

2021-07-28

12.25x

2021-07-27

11.46x

2021-07-26

11.32x

2021-07-23

11.52x

2021-07-22

11.64x

2021-07-21

11.75x

2021-07-20

11.43x

2021-07-19

11.20x

2021-07-16

11.11x

2021-07-15

11.23x

2021-07-14

11.17x

2021-07-13

11.58x

2021-07-12

11.99x

2021-07-09

12.60x

2021-07-08

12.25x

2021-07-07

12.13x

2021-07-06

12.37x

2021-07-02

12.60x

2021-07-01

13.27x

2021-06-30

12.72x

2021-06-29

12.80x

2021-06-28

12.48x

2021-06-25

12.16x

2021-06-24

11.90x

2021-06-23

11.70x

2021-06-22

12.10x

2021-06-21

11.93x

2021-06-18

11.70x

2021-06-17

12.10x

2021-06-16

11.90x

2021-06-15

11.67x

2021-06-14

11.49x

2021-06-11

11.75x

2021-06-10

11.93x

2021-06-09

11.96x

2021-06-08

11.99x

2021-06-07

12.08x

2021-06-04

11.43x

2021-06-03

11.61x

2021-06-02

11.90x

2021-06-01

11.43x

2021-05-28

12.05x

2021-05-27

12.22x

2021-05-26

12.16x

2021-05-25

11.52x

2021-05-24

11.87x

2021-05-21

11.55x

2021-05-20

11.67x

2021-05-19

11.41x

2021-05-18

11.43x

2021-05-17

11.43x

2021-05-14

11.70x

2021-05-13

10.85x

2021-05-12

10.62x

2021-05-11

10.88x

2021-05-10

11.22x

2021-05-07

11.99x

2021-05-06

12.57x

2021-05-05

12.80x

2021-05-04

12.45x

2021-05-03

12.83x

2021-04-30

12.86x

2021-04-29

12.89x

EV/EBITDA Ratio: N/A

OPK EV/EBITDA Ratio Chart

OPK Average EV/EBITDA Ratio Chart

OPK EV/EBITDA Ratio Metrics

OPK Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

EV/EBITDA Ratio FAQ

OPK EV/EBITDA Ratio History

Related Metrics